iCURE helps a first-generation American reach her goal
May 6, 2019
Anaisa Quintanilla-Arteaga’s ultimate goal is to be the Latina scientist she wishes she had seen when she was younger, and “hopefully help younger generations of Latinas realize that they belong and can thrive in STEM, too.” An iCURE fellowship is helping her achieve that dream. Read more...
Undergraduate Research Scholar Program fellow continues her pursuit of science
Apr 25, 2019
Megan Andres is an NIH Undergraduate Scholarship Program (UGSP) fellow with Beverly Mock, Ph.D., Deputy Chief of the Laboratory of Cancer Biology and Genetics. The UGSP program offers competitive scholarships to students from disadvantaged backgrounds who are committed to careers in biomedical, behavioral and social science health-related research. She is hoping to make a difference in possible treatment options for children with Burkitt lymphoma. Read more...
African Postdoctoral Training Initiative fellow looks forward to collaborating within NCI
Apr 18, 2019
Rania Labib, Ph.D., is a postdoctoral fellow in the NIH African Postdoctoral Training Initiative (APTI) working in the lab of Beverly Mock, Ph.D., Deputy Chief of the Laboratory of Cancer Biology and Genetics. As part of the fellowship, she will spend two years at NCI conducting initial experiments in Dr. Mock’s lab, where she hopes to make a difference in possible treatment options for children with Burkitt’s lymphoma. Read more...
Recap: Grand Rounds with Felicia Knaul, Ph.D.
Feb 19, 2019
Nearly 200 CCR staff attended a special Grand Rounds lecture this month featuring Felicia Knaul, Ph.D., an expert in palliative care. Dr. Knaul, a professor at the Leonard M. Miller School of Medicine and Director of the University of Miami Institute for Advanced Study of the Americas, discussed the unequal access to pain and palliative care around the world, particularly related to morphine for pain relief, and the critical importance of educating providers.The lecture, held February 1, was sponsored by CCR’s Women Scientist Advisors (WSAs). Read more...
Watch new Neuro-Oncology Branch video on NCI YouTube
Jan 10, 2019
The Neuro-Oncology Branch is comprised of an exceptional team of experts across scientific disciplines and medical specialties dedicated to developing new treatments for patients with brain and spine cancers using the latest technologies. Learn more about this department. Read more...
Glassdoor recognizes NIH as one of the best places to work
Dec 31, 2018
NIH has been recognized as one of the best places to work by Glassdoor and the Partnership for Public Service. Glassdoor rankings were “determined by the people who know these companies best - their employees.” The Partnership for Public Service rankings were determined by the views of more than 847,000 civil servants from 488 federal organizations on a wide range of workplace topics. Read more...
View the new NCI-CONNECT video on YouTube
Dec 27, 2018
NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) aims to advance the understanding of rare adult central nervous system (CNS) cancers by establishing and fostering patient-advocacy-provider partnerships and networks to improve approaches to care and treatment. Learn more about NCI-CONNECT through this new video. Read more...
New CCR publication, Horizons, is now available
Dec 18, 2018
As Nobel-Prize-winning physicist Niels Bohr once said, “Prediction is very difficult, especially about the future.” Yet, several areas of research that promise new understanding and treatments of cancer are coming into view. In this magazine, we highlight several areas of investigation likely to shape future research conducted in CCR. The collection in Horizons is by no means complete but seeks to capture some of the major areas that will influence our future work. Read more...
Renewed research focus on the human T-cell leukemia virus
Nov 9, 2018
Human T-cell leukemia virus-1(HTLV-1) is the only known retrovirus to directly cause cancer in humans. Infection with this retrovirus affects millions of people worldwide, but currently there is neither a targeted antiretroviral therapy nor a vaccine available. “The discovery of novel preventive or therapeutic remedies for this retrovirus could relieve not only the suffering of HTLV-1 infected individuals but also augment understanding of other chronic infections with cancer viruses,” says Genoveffa Franchini, M. D., Senior Investigator in the CCR Vaccine Branch who has conducted pioneering work on the retrovirus. Read more...
Lung Cancer Research
Nov 1, 2018
November is Lung Cancer Awareness Month. Our research portfolio includes investigators making important discoveries in lung cancer research. Read more...